Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Wynckel

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2019
Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkersFleuria Meibody, Matthieu Jamme, Vassilis Tsatsaris, et al.
Eclinicalmedicine|March 17, 2022
Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort studySophie Demotier, Anne Limelette, Alexandre Charmillon, et al.
Kidney International Reports|June 11, 2020
Spondyloarthritis-Associated IgA NephropathyNicolas Champtiaux, Frédéric Lioté, Khalil El Karoui, et al.
Journal of the American Society of Nephrology : JASN|September 26, 2024
Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy PhenotypeJulia Roquigny, Marie-Sophie Meuleman, Carine El Sissy, et al.
American Journal of Hematology|March 6, 2015
Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference centerYgal Benhamou, Jean-Luc Baudel, Alain Wynckel, et al.
Critical Care Medicine|September 20, 2011
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference CenterAntoine Froissart, Marc Buffet, Agnès Veyradier, et al.
JAMA|December 7, 2017
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical TrialFrank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, et al.
American Journal of Hematology|January 31, 2017
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centreMaximilien Grall, Elie Azoulay, Lionel Galicier, et al.
Medicine|October 27, 2015
Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic PurpuraMélanie Roriz, Mickael Landais, Jonathan Desprez, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 27, 2019
Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkersFleuria Meibody, Matthieu Jamme, Vassilis Tsatsaris, et al.
Eclinicalmedicine|March 17, 2022
Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort studySophie Demotier, Anne Limelette, Alexandre Charmillon, et al.
Kidney International Reports|June 11, 2020
Spondyloarthritis-Associated IgA NephropathyNicolas Champtiaux, Frédéric Lioté, Khalil El Karoui, et al.
Journal of the American Society of Nephrology : JASN|September 26, 2024
Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy PhenotypeJulia Roquigny, Marie-Sophie Meuleman, Carine El Sissy, et al.
American Journal of Hematology|March 6, 2015
Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? Experience of the French thrombotic microangiopathies reference centerYgal Benhamou, Jean-Luc Baudel, Alain Wynckel, et al.
Critical Care Medicine|September 20, 2011
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference CenterAntoine Froissart, Marc Buffet, Agnès Veyradier, et al.
JAMA|December 7, 2017
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical TrialFrank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, et al.
American Journal of Hematology|January 31, 2017
Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centreMaximilien Grall, Elie Azoulay, Lionel Galicier, et al.
Medicine|October 27, 2015
Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic PurpuraMélanie Roriz, Mickael Landais, Jonathan Desprez, et al.
Plos One|May 4, 2010
Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experiencePaul Coppo, Michael Schwarzinger, Marc Buffet, et al.
Pageof 6